SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-011157
Filing Date
2023-07-17
Accepted
2023-07-17 06:30:25
Documents
1
Period of Report
2023-07-13

Document Format Files

Seq Description Document Type Size
1 form4-07172023_060720.html 4  
1 form4-07172023_060720.xml 4 4597
  Complete submission text file 0001415889-23-011157.txt   6039
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UNITED THERAPEUTICS CORPORTION 1735 CONNECTICUT AVE. NW WASHINGTON DC 20009
Business Address
Giltner Richard (Reporting) CIK: 0001460472 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 231090464